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Abstract
Inflammatory Bowel Disease encompasses two diseases, Crohn’s Disease and Ulcerative Colitis.  During the last 70 years the 
evolving of diet in the industrialized countries has led to the utilization of foods that have been processed rather than those in 
their more natural original state .  This increase in the processing of foods has been correlated with the more recent occurrence 
of metabolic diseases such as Inflammatory Bowel Disease.  Patients suffering from this problem exhibit lesser amounts of an-
ti-inflammatory bacteria such as Roseburia and Faecalibacterium and increased amounts of pro-inflammatory bacteria Escheria 
and Fusobacterium.  Since diet directly alters the composition of the gut biome, this review aims to define the role of diet in the 
pathogenesis and management of Inflammatory Bowel Disease.
The Role of Diet in Inflammatory Bowel Diseases
Aviva Smilow
Aviva Smilow graduated with a B.S. degree in Biology in June 2019.
Abbreviations:
IBD – Inflammatory Bowel Disease
CD – Crohn’s Disease
UC - Ulcerative Colitis
Introduction 
What is Inflammatory Bowel Disease?
Inflammatory Bowel Disease (IBD) encompasses two diseases, 
Crohn’s Disease (CD) and Ulcerative Colitis (UC). CD is char-
acterized by inflammation of the digestive tract anywhere from 
mouth to anus. In CD inflammation may reach through many 
layers of the walls of the gastrointestinal tract causing severe 
tissue damage. However, UC occurs when there is an inflamma-
tion of the colon and the rectum. In UC, the inflammation only 
affects the innermost layer of the lining of the colon. There are 
many symptoms for CD and UC. Some of the more common 
ones include diarrhea, abdominal pain, cramping, blood in stool, 
reduced appetite, unintended weight loss and severe bowel con-
striction (Conners, et al., 2017). Many times, inflammation is so 
severe that the intestinal tissue is damaged beyond repair. In the 
event of such inflammation the damaged tissue is removed via 
colectomy. IBD tends to affect individuals of all ages. However, 
IBD is most commonly found in individuals at a young age, inter-
fering with education, work ability, social interaction and basic 
quality of life. Therefore, researchers feel compelled to find res-
olutions for this disease (Lovasz, et.al., 2013).
How the Diet has Changed
Over the centuries the western diet has changed incredibly. In 
the traditional diet, food was produced and consumed shortly 
after harvest. In contrast, much of today’s food supply is pro-
cessed, modified, and transported over great distances before 
being ingested. In recent years, the western diet has been dom-
inated by an increased consumption of refined sugars, omega-6 
polyunsaturated fats and fast food, in addition to a deficiency 
in fruits, vegetables and fiber. The western diet is prevalent in 
industrial countries such as the United States, Canada, Western 
Europe, Australia, and New Zealand, and has been spreading 
and reaching newly developing countries as well (Lovasz, et.al., 
2013). This change in diet has led to the worldwide development 
of many metabolic diseases, such as IBD. (Ng, 2013) (Moschen, 
2012). Recent studies indicate that the incidence rate of IBD in 
developing industrial countries has been increasing in the past 
50 years. This increase suggests that IBD may be triggered by an 
environmental factor (Martinez & Chang, 2013). Although many 
studies have been done, there is still no definite pathogenic 
pathway nor cure for this disease.
Recent research suggests that diet is the key environmen-
tal risk factor in IBD pathogenesis. IBD is an intestinal disease 
and is associated with a dysbiosis in the gut microbiota, the 
microbe population found in the intestine (Reddavide, et al., 
2018).  In general, IBD patients have been found to have lower 
amounts of anti-inflammatory bacteria such as Roseburia and 
Faecalibacterium and have increased amounts of pro-inflamma-
tory bacteria Escheria and Fusobacterium (Aleksandrova, et.al., 
2017). Many studies have shown that one’s diet directly alters 
microbe composition, making diet a pivotal risk factor of IBD. 
Moreover, changes to the traditional diet of newly industrialized 
countries can be linked to the increasing incidence of IBD. The 
purpose of this review is to define the role of diet in the patho-
genesis and management of IBD.
Methods
Critical analysis of peer reviewed articles and clinical research 
papers were used to write this review paper. Articles were ob-
tained from the Touro College online library in order to deter-
mine the relationship between diet and IBD.
Discussion: 
IBD and Gut Microbes
The gut microbiome is an ecosystem, often referred to as a 
Super Organ (Dolan, 2017). The microbes live in a symbiont 
relationship with the host, performing beneficial tasks such as 
nutrient production, development and maturation, regulation 
of immune system and preventing the growth of harmful mi-
croorganisms (Aleksandrova, et.al. 2017). Dysbiosis, which is an 
alteration to the gut flora, can cause disruption to these vital 
tasks. Several studies show that IBD is correlated with altered 
composition of gut microbes in the intestines. 
Interestingly, Studies have shown, that there is an age-related 
variation of IBD onset with three distinct stages. Early onset is 
less than 10 years of age, with a peak onset at 15-30 years old, and 
late onset cases occur at 60 years old. These changes correspond 
to the change in the microbiome’s stability and diversity. Early 
life is associated with a microbiome of minimal complexity and 
stability and can be affected by diet change, illness and puberty. 
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As individuals reach adulthood, the microbiome stabilizes and 
shows improved resilience, but the composition may be altered. 
Correspondingly, decreased stability is often observed in the el-
derly (Kostic, et.al., 2013). Considering this, the microbe compo-
sition and stability in the gut is a key factor in IBD progression.
One role of the microbiota is to maintain a healthy mucosa 
by the production of anti-inflammatory interleukins. This is the 
production of SCFA- short chain fatty acids such as butyrate, 
succinate, lactate, phenols, thiols, and indoles (Reddavide, et al., 
2018). These SCFA act as energy for colonocytes which protect 
against inflammatory responses (Frank, 2007). Patients suffer-
ing from IBD have reduced levels of beneficial SCFA producers 
Bacteroidetes, Lachnuspiraceace, and Ruminococcaceae (Martinez & 
Chang, 2013). An Additional study shows that IBD patients show 
reduced levels of several other SCFA producing bacteria such as 
Calibacterium praunsnizti and Roseburia (Dolan, 2017). This shows 
a direct link between dysbiosis and IBD. 
Another task of the gut microbiome is to maintain the mucus 
layer of the colon and the small intestine. If the mucus layer is in-
tact the gut flora will not directly interact with the epithelial cells 
and inflammation will not occur. However, there is an adherent 
invasive strain of E . coli that is found in abundance in IBD patients 
compared with controls. These invasive bacteria can potentially 
invade epithelial tissue and induce granuloma formation during 
inflammation.  A second group of invasive bacteria Fusobacteria 
is found in abundance in the colon mucosa of IBD patients. 
Fusobacterium varium have been found to cause colon mucosa 
erosion, indicating the possibility of the influence of Fusobacterium 
varium on the pathogenesis of IBD (Kostic, et. al. , 2013). 
Bile Acid signaling is another point where host, microbe and 
even dietary factors all come together. Bile acids assist in diges-
tion and emulsification of fats to be absorbed in the intestines. 
These bile acids are made in the liver from cholesterol. After 
undergoing conjugation to glycine or taurine, the bile acids are 
released in to the digestive tract. In the intestines, deconjuga-
tion of bile acids occurs through Bile Salt hydroxylase (BSH) 
enzymes, making the bile acids functional. These BSH enzymes 
are made exclusively by bacteria, making the bile acid composi-
tion in the intestine dependent on the microbiota composition. 
The two products of bile acid metabolism act as ligands for 
FXR (Farnesoid X receptor) and TGR5 (G protein-coupled bile 
acid receptor 1), which act as signals for anti-inflammatory and 
barrier function. It was found that IBD patients have increased 
levels of conjugated bile acids compared to the control group, 
making these patients prone to inflammation. Furthermore, 
when bile acids are increased in the gut, it can promote growth 
of pathobionts such as Bilophila Wadsworth, which is known to 
induce inflammation (Dolan, 2017). 
On the other hand, many microbes perform protective tasks 
when enriched in the host. Bacteroides and Clostridium species 
have been shown to cause expansion of T-cells and reduce 
inflammation. Additionally, many bacteria can reduce intestinal 
inflammation by regulating nuclear factor (NF)κB activation. 
Faecalibacterium praunsnizti has anti-inflammatory properties 
and is underrepresented in patients with IBD. Many species, such 
as Bifidobacterium, Lactobacillus and Faecalibacterium, protect the 
host from mucosal inflammation by down regulating inflamma-
tory cytokines or stimulating IL-10 anti-inflammatory cytokines 
(Kostic, et. al., 2013). Lastly, intestines rich in Bacteroidetes are 
shown to initiate host responses that protect the host from 
lethal infectious colitis (Brown, et. al., 2012).  
Due to this connection between IBD and dysbiosis, there 
are many current treatments for IBD that are directed at the 
microbiota. Many antibiotics such as ciprofloxacin, metronida-
zole, the combination of both rifaximin and anti-tuberculous 
regimens are used to treat IBD (Nitzan, et.al., 2016). Normally 
antibiotics may cause thinning of the mucus layer, weakening the 
barrier function, leading to increased gut infections. Additionally, 
antibiotics tend to cause an increase in E. coli composition in 
the gut, which is a distinctive feature in intestinal inflammation. 
However, studies show that brief exposure to antibiotics causes 
slight changes to the microbiota in IBD patients that provides 
relief from symptoms. Alternatively, repeated exposure of the 
same antibiotic causes persistent changes to the microbiota 
leading to infection (Kostic, et.al., 2013).  Due to this contro-
versy of antibiotics, in the last few years methods to repopu-
late the gut with healthy beneficial microbes has been gaining 
popularity as a potential treatment for IBD. Evidence shows 
that Fecal Microbiota Transplantation (FMT) can be effective in 
replenishing a healthy microbiota. FMT, also known as a stool 
transplant, is the transplantation of gut microbes from the stool 
of a healthy individual into the recipient. There has been a high 
success rate for FMT in many other metabolic diseases such 
as relapsing C. difficile infection. Therefore, researchers are con-
sidering FMT for other gastrointestinal illnesses such as IBD. 
Additional studies are needed to determine the outcome of 
FMT on IBD patients (Kostic, et.al., 2013). 
It is now clear that IBD is inherently linked with dysbiosis. 
There are many factors that can cause dysbiosis such as genet-
ics, immune function, and diet. Genetic susceptibility is the most 
obvious factor. IBD patients carrying a mutation in a NOD2 
related gene, have increased numbers of mucosa adherent bac-
teria, as well as significant alterations in bacterial composition 
(Kostic, et. al., 2013). Studies have shown that CD is common in 
the Ashkenazi Jewish population. Many studies were done using 
large families of Ashkenazi Jews to determine a genetic vari-
ant cause to CD.  One study found the haplotype 268SJW1 on 
chromosome 16 to contribute to the risk of CD in Ashkenazi 
Jews (Sugimura, 2003). Although genetic susceptibility cannot be 
ignored, due to the increasing incidence rates of IBD, research-
ers believe that environmental factors are the core triggers.
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Dietary Factors effecting the Microbiome
Diet is suspected to be the prime contributor to the patho-
genesis of IBD. Dietary composition has been proven to be 
associated with intestinal inflammation by directly or indirect-
ly modifying the gut microbiome (Reddavide, et al., 2018). So, 
current research is aimed at examining how diet changes the 
microbiome and how these changes affect the host, in order 
to determine foods that can cause or prevent inflammation 
(Kostic, et.al., 2013).
In a study done, subjects were put on a western-style diet for 
one month and showed a 71% increase in plasma endotoxins. 
The western diet is characterized by a high fat diet and therefore 
may cause endotoxemia by causing changes in the intestinal bar-
rier function or microbiota composition (Pendyala, et.al., 2012). 
Another study showed that mice fed a high fat diet were associated 
with endotoxemia and systemic inflammation. These mice showed 
lowered amounts of Bifidobacterium spp, indicating that this species 
of bacteria have anti-inflammatory properties (Cani, 2007).
Variations in long term diet patterns change the ratios of 
Bacteroides, Prevetolla, and Firmicutes. However, modifications in 
short term diets have no significant influence. It has been deter-
mined that enriched protein and animal fat diets, common in the 
western diet, favored Bacteroides. Diets rich in carbohydrates, 
such as in agrarian societies, favored Prevetolla (Wu, 2011). 
Switching to a high fat diet causes a decrease in Bacteroides and 
an increase of Firmicutes and Proteobacteria (Hildebrandt, 2009). 
It has been proven that protein rich diets increase enzymes that 
produce toxic metabolites which trigger inflammatory response 
(Brown, DeCoffe, et.al., 2012). 
Another microbe often associated with IBD inflammation 
is Bilophila Wadsworth, a sulfite producing bacteria. In a recent 
study when mice were fed a milk fat enriched diet, it led to 
a series of reactions that ultimately led to an abundance of 
Bilophila Wadsworth. Although there is no precise mechanism for 
how it causes inflammation, there are many hypotheses (Frank, 
2007). Furthermore, an interesting study concluded that refined 
dietary glucose intake can change microbe composition and in-
crease intestinal inflammation (Whitehead, 2011).  A strict Vegan 
or Vegetarian diet led to a significant reduction in Bacteroides 
spp, Bifidobacterium spp, and the Enterobactericeae which helps 
manage inflammation of IBD (Enck, 2011). 
A further connection between diet, microbes, and host in-
flammation has been discovered through studies of the intes-
tinal function of the aryl hydrocarbon receptor (AhR). AhR is 
a nuclear receptor that activates certain metabolic genes. AhR 
also plays a key role in adaptive immunity through the regula-
tion of T-cell activity. IBD patients have a decreased expression 
of AhR which may cause pro-inflammatory immune activation 
conditions. It has been discovered that certain gut microbes can 
produce AhR agonists. IBD patients contain less amounts of the 
microbes necessary to produce these agonists. An important 
dietary source of AhR ligands are found in cruciferous vegeta-
bles such as cauliflower, broccoli, brussels sprouts and bok choy. 
This may explain why these vegetables have a protective effect 
on IBD risk (Dolan, 2017). 
One major role of the microbiota is to act as an immune sys-
tem of the host. The gut flora protects the host from pathogens 
by maintaining the integrity of the intestinal mucosa. Dysbiosis 
can cause a disruption in the intestinal mucosa and allow access 
for pathogens which can lead to reactions which cause inflamma-
tion and eventually tissue damage. Many studies were conducted 
to determine the influence of micro and macro nutrients on im-
munity. Many micronutrients are essential for immunonutrition 
such as vitamins A, C, D, E, folic acid, zinc, and iron (Reddavide, et 
al., 2018). Deficiencies in vitamins A and D may reduce function 
of natural killer cells, while supplemental zinc and vitamin C 
can increase their activity. Vitamin D is important in intestinal 
function for it is known to suppress microbial invasion into the 
epithelium. 82% of IBD patients have been found to have vitamin 
D deficiencies which have been linked to a weakened epithelial 
barrier. Although studies have been done to determine the ef-
fects of vitamin D supplements on IBD patients, more research 
is needed. Furthermore, Iron deficiencies have been associated 
with faulty T cell response and weakened cytokine production. 
However, iron supplements have been shown to have a negative 
effect on IBD patients by increasing an individual’s susceptibili-
ty to infections. It is evident that micronutrients can affect the 
immune system thereby causing dysbiosis and the onset of IBD 
(Aleksandrova, et.al., 2017). More research is needed to recog-
nize optimal nutrient levels and therapeutic options.
These findings support the fact that the microbiota is di-
rectly related to food quality. Diet influences the composition 
of the microbiota and thereby controls IBD pathogenesis. The 
current diet is significantly different than the diet of previous 
generations when the prevalence of IBD was not as widespread. 
Countless experiments were performed to see the effects of 
diet on IBD. Dietary factors can have a negative effect on IBD 
and increase inflammation, or they can have a protective or even 
healing effect on patients with IBD.
Dietary Risk Factors of IBD
Refined and processed carbohydrates are risk factors for IBD, 
but complex carbohydrates, such as fruits, vegetables, or fibers 
can help manage IBD. A diet high in animal protein was cor-
related with a 3.3-fold increased risk in IBD (Reddavide, et al., 
2018). Individuals that consumed milk products including milk, 
yogurt and cheese, had a lower chance of developing IBD. This 
suggests that dairy intake has no risk effect on IBD and may 
even have a protective effect (Malavia, 2017). Many studies were 
done on the effects of fat intake on IBD. Although it is known 
that a typical high fat western diet has a negative effect on IBD, 
it is unclear which specific fats cause that.  One study showed 
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that an increase in poly-unsaturated fatty acids was positively 
associated with IBD (Parekh, 2015). Another study concluded 
that long term intake of trans-unsaturated fatty acids is associ-
ated with a trend towards IBD. Evidence shows that excessive 
consumption of omega-6 poly-unsaturated fatty acids increases 
the risk of IBD, while consumption of omega-3 poly unsaturated 
fatty acids is associated with a decrease in one’s risk for the 
onset of the disease (Brown, et. al., 2012). 
Dietary Management in IBD
Interestingly, research has shown that the Mediterranean Diet, due 
to its unique balance of fat, is directly correlated with decreased 
inflammation. The Mediterranean Diet (MD) is characterized by 
fruits and vegetables rich in fiber, vitamins, and antioxidants, whole 
grains, and nuts, as well as olive oil and oily fish that are high in 
poly and mono unsaturated fatty acids. Each item in the diet pro-
vides benefits to patients with IBD (Serra-Majem, 2009).
Legumes, a major part of the MD, contain soluble fibers that 
do not aggravate the gut microbes. Furthermore, legumes tend 
to have a prebiotic action and promote the growth of beneficial 
SCFA producing microbes which protect the gut mucosa. Fruits 
and vegetables have a naturally high fiber content and therefore 
using a juicer to extract the essential vitamins and minerals 
showed best results when treating IBD patients. Recent studies 
claim that olive oil has ani-inflammatory effects. This is due to the 
synergic action of its oleic acid with other antioxidant molecules. 
Grains that were proven to have the most beneficial effect were 
unmodified grains. These grains have low immunogenic impact 
and do not cause inflammation in the gut mucosa. Bluefish, which 
is popular in the MD, is shown to have anti-inflammatory effects 
due to its omega-3 fats EPA and DHA (Reddavide, et al., 2018). 
An alternative diet that has shown promise in IBD manage-
ment is the Specific Carbohydrate Diet (SCD). This diet works 
with the hypothesis that patients with IBD can not break down 
disaccharides and amylopectin. Large amounts of disaccharides 
can lead to an over growth of microbes and cause IBD relat-
ed symptoms. Therefore, the SCD is a strict monosaccharides 
diet excluding disaccharides and most polysaccharides. The diet 
includes vegetables with a high amylose to amylopectin ratio. 
The real potential for this diet is in the maintenance of IBD 
patients in remission to help maintain a healthy gut microbiome 
(Reddavide, et al., 2018). A similar diet the FODMAP – Low 
Fermentable oligosaccharide disaccharide monosaccharide and 
polyols diet also showed significant improvement of symptoms 
in patients with IBD (Dolan, 2017). Although these findings 
clearly define the effects of diet on IBD, the role of diet does 
not stop there. 
Dietary Factors and Epigenetics
New emerging evidence points to epigenetics as a major com-
ponent of IBD pathogenesis. Epigenetics is the study of heritable 
changes in gene expression that do not involve changes in the 
actual DNA sequence. This leads to a change in phenotype with-
out a change in genotype. Epigenetic modifications, such as his-
tone modifications, influence DNA accessibility and chromatin 
structure, thereby effecting the regulation of gene expression. 
The body uses epigenetic modifications as natural ways to con-
trol gene expression as needed throughout one’s life. However, 
epigenetic changes can also be induced by external factors in-
cluding age, the environment, lifestyle, and disease state. Dietary 
factors have been shown to contribute to IBD in an indirect 
manner via epigenetics (Reddavide, et al., 2018). 
Over time, researchers have discovered new methylation 
patterns emerging for IBD. Many therapeutic studies were done 
to try to counteract this methylation using drugs and other 
processes. However, researchers found it difficult to pinpoint 
the methylation in specific tissue and to predict drug response 
in clinical trials so other strategies were considered. Dietary 
factors have been known to alter epigenetics which can influ-
ence an immune response that can potentially offset inflam-
mation. Therefore, scientists looked at dietary components 
for a solution to IBD methylation patterns. It was discovered 
that secondary plant metabolites, such as polyphenols, have 
been demonstrated to inhibit DNA methyltransferase activity. 
Furthermore, gut microbiome has been shown to alter host 
histone acetylation and methylation in human colon tissues. 
Interestingly, SCFA, which is generally produced from microbial 
fermentation of fibers, is shown to be important in epigenetic 
regulation of inflammatory responses. It was determined that 
a lack of SCFA can disturb chromatin effects. This deficiency of 
SCFA can be a result of a diet low in fiber or a decrease in ben-
eficial SCFA producing bacteria. As mentioned previously, IBD 
patients have been found to have low amounts of Bacteroidetes, 
Lachnuspiraceace, Ruminococcaceae, Calibacterium praunsnizti, and 
Roseburia, SCFA producing bacteria, making IBD patients sus-
ceptible to epigenetic changes which can lead to inflammation. 
(Reddavide, et al., 2018).
Other Environmental Factors
Although diet has been presumed to be the primary trigger for 
IBD, there are many other environmental factors that can prompt 
IBD symptoms. Smoking, and stress are such factors that have 
also been shown to influence IBD pathogenesis. Interestingly, 
Smoking has been found to be negatively associated with UC 
but positively associated with CD. Patients who did smoke 
only developed UC after they ceased smoking. Additionally, 
male UC patients who smoked during disease progression, re-
ported reduced symptoms and had lower hospitalization rates 
compared to non-smokers. Increased colectomy rates were 
seen in non-smokers and ex-smokers than in current smok-
ers. Also, reduced rates of relapse were seen in patients who 
began smoking after the onset of UC. On the other hand, many 
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studies show an increased risk of CD in smokers compared to 
non-smokers. There is a 34% increased relapse rate for CD in 
smokers. Furthermore, severe lesions at the anatomic sight have 
developed more in smokers than non or ex-smokers in CD 
patients (Thomas, et.al., 2000).  
There are many theories for the possible mechanism of the 
influence smoking has on IBD. Firstly, due to the interrelationship 
of gut microbes and immunity, researchers studied how smok-
ing influences the immune system. Studies show that changes in 
T cells, such as increased levels of suppressor OKT8+ cells and 
a decreased ratio of OKT4+ to OKT8+ cells have been seen 
in heavy smokers. Remarkably, these changes revert to normal 
range once a patient terminates smoking. The low levels of IgA’s 
in the saliva and intestinal secretion of smokers dictates an addi-
tional immune effect. The IgA antibody is a vital component of se-
cretions that lubricate the mucosal surfaces which act as the first 
line of defense in the immune system. Therefore, patients who 
smoke will already have a weakened immune system. Another 
possible mechanism involves the inflammatory pathway. Nicotine, 
a substance found in most cigars and cigarettes, is known to 
effect cytokine production in the body, specifically by reducing 
pro-inflammatory cytokines. Also, certain eicosanoids, which are 
correlated with inflammation, are seen in decreased amounts in 
smokers. This may be the cause to the negative effect of smoking 
on UC patients. Nevertheless, smokers show lower levels of two 
interleukins, IL-1β and IL-8, which help regulate inflammatory 
response. Lastly, smoking may also influence IBD via intestinal 
mobility. One major symptom of IBD is issues with bowel move-
ment and defecation. It has been found that nicotine can affect 
the intestinal motility at many sites. Nicotine relaxes the smooth 
muscles of the intestine and therefore reduces contractile activity 
during bowel movement (Bhatti, 1997). These mechanisms por-
tray the direct influence that smoking may have on IBD. 
Another environmental factor that researchers have discov-
ered to be effective in the pathogenesis of IBD, is stress related 
influences. In earlier years IBD was classified as a psychosomatic 
disorder. Although this classification had been long disproved, it 
does represent the deep relationship between stress and IBD. 
In general, stress acts as a threat to an organism’s homeostasis. 
Therefore, the body will exert mechanisms to maintain equi-
librium in the face of any stress. There are two interconnected 
pathways in the body that govern stress related responses; the 
HPA axis - hypothalamic pituitary adrenal axis and the ANS - au-
tonomic nervous system. The pathway of the HPA axis begins 
when stress stimulates the release of corticotropin releasing 
hormone from the hypothalamus. This causes the release of ad-
renocorticotropic hormone from the anterior pituitary gland 
which then stimulates the secretion of cortisol from the adre-
nal cortex. Cortisol then travels throughout the blood stream 
causing changes all around the body to help deal with stress. The 
pathway of the ANS involves the stress induced activation of 
pontomedullary nuclei, which control autonomic responses. As 
a response to stress, adrenaline and noradrenaline are released 
from the adrenal medulla via the stimulation of the sympathetic 
nervous system. Furthermore, The HPA axis and ANS are key 
modulators of the rich nerve supply of the gut, the ENS – enteric 
nervous system. The ENS is composed of 100 million neurons 
that regulate functions of the gastrointestinal tract. The term 
“Brain-Gut Axis” refers to this complex network of neurons of 
the HPA axis, ANS, and ENS (Mawdsley, 2005). 
The actual pathway of the Brain-gut axis response to stress is 
complex. Various interconnected activities occur in both the gut 
and around the body in response to stress that can lead to inflam-
mation. Specifically, in the gut, in response to stress, inflammatory 
cytokines, SCFA, and microbial products can alter the ANS and in 
turn lead to the secretion of cortisol and adrenaline. Also, under 
stress, the gut microbiota and mast cells can release various 
chemicals such as histamine or serotonin which are known to 
impair the intestinal secretion and intestinal mucosa, which can 
lead to inflammation. There are many stressors that can affect the 
intestinal mucosa’s permeability, making a host predisposed for 
infections and inflammation (Brzozowski, 2016).
Due to this intimate correlation between the nervous system 
and the gut, it is obvious that stress can influence the patho-
genesis of IBD. Chronic heightened stress has been determined 
to have an important role in predicting the relapse of IBD in 
patients in remission (Mawdsley, 2005). Also, mice that were 
induced with depression demonstrated an increase in inflam-
mation which was modulated by an increase in pro-inflamma-
tory cytokines secreted by macrophages (Brzozowski, 2016). 
Although researchers have not determined an absolute direct 
pathway for the control of stress on inflammation, there are 
many suggestions. Many propose that patients with IBD have 
altered HPA axis functioning, which may explain the relation 
of stress to IBD symptoms. Interestingly, cortisol, which is 
released under stress, is known to have anti-inflammatory ef-
fects. However, in patients with UC, levels of cortisol showed 
no correlation to the levels of inflammatory cytokines. On the 
other hand, others hypothesized that due to the high levels of 
inflammatory cytokines in the blood of active IBD patients, the 
response of the HPA axis and thereby the response of cortisol 
may be dampened. Likewise, stress is known to impact gastro-
intestinal motility, and water and ion secretion. While these are 
non-inflammatory effects, they may contribute to the non-in-
flammatory symptoms of IBD patients (Mawdsley, 2005). The 
above mechanisms demonstrate the correlation between stress 
and IBD, making psychological factors a key influence in the 
pathogenesis of IBD. 
Conclusion
The intestinal microbiota performs vital jobs in host metabo-
lism making its composition vital to the host’s health. Dysbiosis, 
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which is found in IBD, can be caused by several different factors. 
While genetics and other environmental factors cannot be ig-
nored, an altered microbiota resulting from diet-induced dysbi-
osis may also be a factor that contributes to the inappropriate 
inflammatory responses that occur. As our understanding of the 
microbiota continues to grow, promoting microbes to prevent 
or control inflammatory-mediated diseases through diet may 
represent an exciting therapeutic avenue.
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